✦ LIBER ✦

Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis

✍ Scribed by J. K. HENNAN; G. A. MORGAN; R. E. SWILLO; T. M. ANTRILLI; C. MUGFORD; G. P. VLASUK; S. J. GARDELL; D. L. CRANDALL

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Specific PAI-1 Inhibitor, PAI-039, Red

✍ Lee, S.; Eren, M.; Vaughan, D.E.; Cho, S.H. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

12 A monoclonal antibody inducing the su

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 125 KB

The Antithrombotic Effects of CI-1028, a

✍ Thomas B. McClanahan; Gary W. Hicks; Diane P. Ignasiak; Richard Bousley; Thomas 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 111 KB

Effects of R-102444, an orally active 5-

✍ Taketoshi Ogawa; Atsuhiro Sugidachi; Naoki Tanaka; Koichi Fujimoto; Fumitoshi As 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 371 KB

A small molecule, orally active, α4β1/α4

✍ Julio Cortijo; María-Jesús Sanz; Arantxa Iranzo; José Luis Montesinos; Yafa Naim 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 409 KB

Effects of 2-[N-(4-Chlorophenyl)-N-methy

✍ Yamashita, H. 📂 Article 📅 2003 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 146 KB